Involvement of the Neutral Amino Acid Transporter SLC6A15 and Leucine in Obesity-Related Phenotypes

• Jana Drgonova,

  Affiliation Molecular Neurobiology Branch, NIH-IRP, NIDA, Baltimore, Maryland, United States of America

  ⨯
• Josefin A. Jacobsson,

  Affiliation Unit of Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden

  ⨯
• Joan C. Han,

  Affiliation Section on Growth and Obesity, Program in Developmental Endocrinology and Genetics, NICHD-IRP, NIH 10 CRC, Bethesda, Maryland, United States of America

  ⨯
• Jack A. Yanovski,

  Affiliation Section on Growth and Obesity, Program in Developmental Endocrinology and Genetics, NICHD-IRP, NIH 10 CRC, Bethesda, Maryland, United States of America

  ⨯
• Robert Fredriksson,

  Affiliation Unit of Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden

  ⨯
• Claude Marcus,

  Affiliation Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Helgi B. Schiöth,

  Affiliation Unit of Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden

  ⨯
• George R. Uhl

  * E-mail: guhl@intra.nida.nih.gov

  Affiliation Molecular Neurobiology Branch, NIH-IRP, NIDA, Baltimore, Maryland, United States of America

  ⨯